Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-09-06Clinical Trial Update: A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants [Phase 1]
Phase 1 study evaluating pharmacokinetics of a single IV 300 mg dose of vedolizumab in healthy adult Chinese participants.
-
FDA approval · 2019-07-23FDA Approved: HADLIMA — Original Application (Organon LLC)
FDA approves Hadlima (adalimumab-bwwd) from Organon as a biosimilar to Humira under the original application BLA761059. It is indicated for …
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Eating Behaviour in Crohn's Disease
A completed clinical trial studying eating behaviour in Crohn's disease has posted results.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease [Phase 3]
TA-650's Phase 3 study in pediatric Crohn's disease has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease [Phase 2]
Phase 2 clinical trial update for Abrilumab (AMG 181) in adults with moderate to severe Crohn's disease; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta [Phase 1]
Phase 1 postmarketing transfer study evaluating Cimzia (certolizumab pegol) from mother to infant via placenta has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)
Completed observational trial evaluating the effectiveness of adalimumab on health and disability outcomes in immune-mediated inflammatory d…
-
FDA approval · 2019-06-13FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental application for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Special Investigation (Long-term Investigation) in Patients With Crohn's Disease
A long-term investigation study in Crohn's disease completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction [NA]
A completed clinical trial evaluating whether small bowel ultrasound can predict response to Remicade induction in Crohn's disease.
-
FDA approval · 2019-05-07FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for ENTYVIO (vedolizumab) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2019-05-06FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ENTYVIO (vedolizumab) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Corticosteroids With Vedolizumab in Crohn's Disease [Phase 4]
Phase 4 clinical trial update for corticosteroids with vedolizumab in Crohn's disease was terminated; results posted in 2019.
-
FDA approval · 2019-04-23FDA Approved: AZATHIOPRINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for azathioprine from Zydus Lifesciences Limited.
-
FDA approval · 2019-04-23FDA Approved: AZATHIOPRINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for azathioprine from Rising Pharma Holdings, Inc., confirming a new generic form of the drug.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) [Phase 3]
Phase 3 trial update on telemedicine for inflammatory bowel disease, including Crohn's disease and related conditions, completed with result…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease [Phase 3]
Phase 3 trial update on adipose-derived stem cells for complex perianal fistulas in Crohn's disease; trial status terminated.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease. [Phase 1, Phase 2]
Clinical trial update for expanded allogenic adipose-derived stem cells (Cx601) in complex perianal fistulas associated with Crohn's disease…
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Adipose Tissue Injection in Perianal Fistulas in Crohn´s Disease [Phase 2, Phase 3]
Clinical trial update on adipose tissue injection for perianal fistulas in Crohn's disease (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease [Phase 4]
Phase 4 clinical trial investigating the effects of parenteral omega-3 polyunsaturated fatty acids on postoperative complications in Crohn's…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease [Phase 2]
Phase 2 trial of andecaliximab in moderately to severely active Crohn's disease was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol [Phase 2]
extension study aimed at assessing long-term safety of certolizumab pegol in children and adolescents with Crohn's disease; completed with …
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease [Phase 3]
Open-label Phase 3 trial update of vedolizumab in ulcerative colitis and Crohn's disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Combined THC and CBD Drops for Treatment of Crohn's Disease [Phase 1, Phase 2]
A combined THC and CBD drop formulation for Crohn's disease has completed Phase 1 and Phase 2 trials.
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…